Stay updated on Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.

Latest updates to the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision value v3.5.4 replaces the previous v3.5.3 on the Record History page, indicating an update to the page version. This update reflects administrative changes rather than user-facing content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s footer shows an updated ClinicalTrials.gov site revision from v3.5.2 to v3.5.3, a change limited to the platform/version label rather than the trial information itself.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision v3.5.0 added and Revision v3.4.3 removed from the study's record history.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the record history.SummaryDifference0.1%

- Check106 days agoChange DetectedRevision v3.4.2 was added to the record history, and the previous funding notice and revision v3.4.1 were deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

Stay in the know with updates to Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.